Stevanato Group S.p.A. (NYSE: STVN)
Health Care · Life Sciences Tools & Services · IT
$19.38
-0.10% today · -20.4% 1Y
Stevanato Group S.p.A. (NYSE: STVN) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $5.30B and employs 6,010 people.
Over the last twelve months the share price has lost 20.4%, trading between 12.89 and 27.99.
Tweenvest scores Stevanato Group S.p.A. across four factors: quality 69/100, value 71/100, growth 75/100, dividend 7/100. Its strongest factor is growth.
STVN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.30B
- Revenue (TTM)
- $1.40B
- P/E
- 34.66
- EPS
- 0.49
- Dividend yield
- 0.31%
- Beta (5Y)
- 0.78
- 52-week high
- $27.99
- 52-week low
- $12.89
- Avg volume (3M)
- —
- Shares outstanding
- 273.13M
- Employees
- 6,010
- Next earnings
- —
About Stevanato Group S.p.A.
Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.
- ISIN
- IT0005452658
- Founded
- 1949
- Listed since
- Jul 16, 2021
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Bruker CorporationNasdaqGS: BRKR | $8.96B | $56.97 | -3.18% |
| Bachem Holding AGSWX: BANB | $7.22B | CHF80.90 | +1.06% |
| Hangzhou Tigermed Consulting Co., LtdSZSE: 300347 | $6.56B | CN¥55.18 | -5.51% |
| Joinn Laboratories(China)Co.,Ltd.SHSE: 603127 | $5.35B | CN¥52.60 | +6.69% |
| Sotera Health CompanyNasdaqGS: SHC | $5.15B | $18.12 | +0.33% |
| Anthem Biosciences LimitedNSEI: ANTHEM | $5.02B | Rs862.30 | +0.77% |
| Adaptive Biotechnologies CorporationNasdaqGS: ADPT | $4.23B | $25.43 | -4.00% |
| MGI Tech Co., Ltd.SHSE: 688114 | $4.18B | CN¥67.95 | -5.49% |
Figures last refreshed Oct 11, 2026.